315 related articles for article (PubMed ID: 8799687)
21. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.
Barry M; Mulcahy F; Merry C; Gibbons S; Back D
Clin Pharmacokinet; 1999 Apr; 36(4):289-304. PubMed ID: 10320951
[TBL] [Abstract][Full Text] [Related]
22. Saquinavir soft-gel capsule formulation. A review of its use in patients with HIV infection.
Perry CM; Noble S
Drugs; 1998 Mar; 55(3):461-86. PubMed ID: 9530549
[TBL] [Abstract][Full Text] [Related]
23. Ritonavir.
Lea AP; Faulds D
Drugs; 1996 Oct; 52(4):541-6; discussion 547-8. PubMed ID: 8891466
[TBL] [Abstract][Full Text] [Related]
24. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
Schapiro JM; Lawrence J; Speck R; Winters MA; Efron B; Coombs RW; Collier AC; Merigan TC
J Infect Dis; 1999 Jan; 179(1):249-53. PubMed ID: 9841849
[TBL] [Abstract][Full Text] [Related]
25. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
[TBL] [Abstract][Full Text] [Related]
26. Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection.
Perry CM; Faulds D
Drugs; 1997 Apr; 53(4):657-80. PubMed ID: 9098665
[TBL] [Abstract][Full Text] [Related]
27. Saquinavir: major study shows survival benefit in treatment-naive patients.
James JS
AIDS Treat News; 1997 Jul; (No 274):6. PubMed ID: 11364463
[TBL] [Abstract][Full Text] [Related]
28. Indinavir: a review of its use in the management of HIV infection.
Plosker GL; Noble S
Drugs; 1999 Dec; 58(6):1165-203. PubMed ID: 10651394
[TBL] [Abstract][Full Text] [Related]
29. The choice of HIV protease inhibitor: indinavir is currently the best option.
Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
[TBL] [Abstract][Full Text] [Related]
30. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
31. Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy.
Vanhove GF; Gries JM; Verotta D; Sheiner LB; Coombs R; Collier AC; Blaschke TF
Antimicrob Agents Chemother; 1997 Nov; 41(11):2433-8. PubMed ID: 9371346
[TBL] [Abstract][Full Text] [Related]
32. What we know so far.
Gazzard B
AIDS; 1996 Nov; 10 Suppl 1():S3-7. PubMed ID: 8970669
[TBL] [Abstract][Full Text] [Related]
33. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
[TBL] [Abstract][Full Text] [Related]
34. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
35. The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients.
Churchill DR; Pym AS; Galpin S; Foxall R; Stainsby C; Clarke JR; Kaye S; Bloor S; Larder BA; Wills B; Sun E; Babiker AG; Back DJ; Weber JN
AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1181-9. PubMed ID: 10480631
[TBL] [Abstract][Full Text] [Related]
36. HIV therapy advances. Update on a proteinase inhibitor.
Vella S
AIDS; 1994 Sep; 8 Suppl 3():S25-9. PubMed ID: 7840913
[TBL] [Abstract][Full Text] [Related]
37. Management of HIV infection in Nigeria with zalcitabine in combination with saquinavir mesylate: preliminary findings.
Akinsete I; Njoku OS; Okanny CC; Chukwuani CM; Akanmu AS;
West Afr J Med; 2000; 19(4):265-8. PubMed ID: 11391837
[TBL] [Abstract][Full Text] [Related]
38. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
Bhana N; Ormrod D; Perry CM; Figgitt DP
Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy with zidovudine, didanosine and saquinavir.
Collier AC; Coombs RW; Schoenfeld DA; Bassett R; Baruch A; Corey L
Antiviral Res; 1996 Jan; 29(1):99. PubMed ID: 8721557
[TBL] [Abstract][Full Text] [Related]
40. Advanced HIV infection treated with zidovudine monotherapy: lifetime values of absolute cost-effectiveness as a pharmacoeconomic reference for future studies evaluating antiretroviral combination treatments. The Osservatorio SIFO sui Farmaci.
Messori A; Becagli P; Berto V; Trippoli S; Font M; Tosolini F; Venturini F; Martini N
Ann Pharmacother; 1997 Dec; 31(12):1447-54. PubMed ID: 9416379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
